These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12892556)

  • 21. Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy.
    Nasri A; Kacem I; Jerdak F; Djebara MB; Mejri N; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Oct; 37(10):1723-5. PubMed ID: 27329274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
    Hayward K; Jeremy RJ; Jenkins S; Barkovich AJ; Gultekin SH; Kramer J; Crittenden M; Matthay KK
    J Pediatr; 2001 Oct; 139(4):552-9. PubMed ID: 11598603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataxia and secretory diarrhea: two unusual paraneoplastic syndromes occurring concurrently in the same patient with ganglioneuroblastoma.
    Gesundheit B; Smith CR; Gerstle JT; Weitzman SS; Chan HS
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):549-52. PubMed ID: 15342979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic opsoclonus-myoclonus syndrome as a presentation of high grade serous ovarian cancer.
    Stewart KT; Lee JS; Stuart G
    Gynecol Oncol Rep; 2019 Nov; 30():100511. PubMed ID: 31828196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response.
    Erlich R; Morrison C; Kim B; Gilbert MR; Alrajab S
    Cancer Invest; 2004; 22(2):257-61. PubMed ID: 15199608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
    Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
    Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
    Singhi P; Sahu JK; Sarkar J; Bansal D
    J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Small cell lung cancer complicated by opsoclonus myoclonus syndrome].
    Iwata T; Yokomura I; Ohsugi S; Uesaka A; Sekiguchi K; Nishio A
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1046-50. PubMed ID: 19994603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia].
    Martinaud O; Guegan-Massardier E; Iasci L; Miret N; Mihout B; Hannequin D
    Rev Neurol (Paris); 2005 Jan; 161(1):81-6. PubMed ID: 15678006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma.
    Scholz J; Vieregge P; Ruff C
    J Neurol Neurosurg Psychiatry; 1994 Jun; 57(6):763-4. PubMed ID: 8006669
    [No Abstract]   [Full Text] [Related]  

  • 31. [Opsoclonus-myoclonus syndrome: a case report].
    Jomir L; Sirvain S; Bouly S; Garrido JF; Hallé O
    Rev Med Interne; 2009 Nov; 30(11):980-1. PubMed ID: 19695745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correspondence: treatment of the neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome with high-dose methylprednisolone.
    Emir S; Akyüz C; Büyükpamukçu M
    Med Pediatr Oncol; 2003 Feb; 40(2):139. PubMed ID: 12461808
    [No Abstract]   [Full Text] [Related]  

  • 33. Opsoclonus-Myoclonus Syndrome in Primary Central Nervous System Lymphoma.
    Grubbs J; Trobe JD; Fisher-Hubbard A
    J Neuroophthalmol; 2016 Dec; 36(4):408-411. PubMed ID: 27023309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opsoclonus-myoclonus syndrome in a child with neuroborreliosis.
    Vukelic D; Bozinovic D; Morovic M; Tesovic G; Ruzic Sabljic E; Barisic N; Knezovic I
    J Infect; 2000 Mar; 40(2):189-91. PubMed ID: 10841099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Opsoclonus myoclonus syndrome: how long are we going to go on researching?].
    Ramos S; Temudo T
    Rev Neurol; 2002 Aug 16-31; 35(4):322-5. PubMed ID: 12235560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic disorders of the central and peripheral nervous systems.
    Didelot A; Honnorat J
    Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.
    Kumar A; Lajara-Nanson WA; Neilson RW
    J Neurooncol; 2005 May; 73(1):43-5. PubMed ID: 15933816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic neurological disorders in children with benign ovarian tumors.
    Hsu MH; Huang CC; Hung PL; Huang HM; Huang LT; Huang CC; Sheen JM; Huang SC; Chang YC
    Brain Dev; 2014 Mar; 36(3):248-53. PubMed ID: 23694758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opsoclonus-ataxia syndrome associated with ovarian mature teratoma.
    Kanno K; Kin S; Hirose M; Suzuki S; Watanabe T; Fujimori K
    J Obstet Gynaecol Res; 2015 Jul; 41(7):1149-53. PubMed ID: 25772013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature.
    Weizman DA; Leong WL
    J Surg Oncol; 2004 Sep; 87(3):143-5. PubMed ID: 15334643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.